• Reduce ventilator days and extubation failures2• Improve oxygenation and ventilation in BiPhasic mode2• Improve apnea of prematurity treatment3• Maximize pressure stability at the lowest work of breathing4 Advanced noninvasive treatment options provide:• CPAP, BiPhasic or BiPhasic trigger (tr)*• Graseby capsule for apnea detection and patient synchronization in BiPhasic tr• Apnea and low breath rate detection, and patient synchronization in BiPhasic tr Safety and versatility is enabled through:• Up to two hours of battery backup• Simple Touch™ operation for ease of use• Fully integrated patient monitoring for easy patient assessment• Fully integrated alarm systems for patient safety

SiPAPvs CPAP

The inaugural CAN GIVE DAY event was held in November 2020; a free live streaming event, starring the Canberra hospital Foundation Ambassador Leo Sayer, to raise funds to buy equipment to bring comfort, understanding and hope to patients and their families. The $5,625 was specifically donated to purchase an Astodia Transilluminator, a trauma-reducing device that helps find veins in tiny arms, and reduces trauma for those needing venipuncture.

For over two decades, the Infant Flow nCPAP System has delivered gentle respiratory support to thousands of neonates worldwide. The Infant Flow SIPAP System, combined with the patented variable flow generator, provides noninvasive positive pressure ventilation, by offering nasal CPAP, bilevel and Biphasic tr* modalities. The Infant Flow nCPAP System takes the work out of breathing, freeing precious calories to be used for growth and development.

Capital Chemist acknowledges the Traditional Custodians of the land on which we operate, live and gather as employees, and recognise their continuing connection to land, water and community.  We pay respect to Elders past, present and emerging.